The present findings, coupled with the extensively reported mechanisms of action, suggest that MCP-1/CCL2 could plausibly be a causal risk factor for PCOS, with important clinical implications on fertility and cardiometabolic risk. This evidence concerns the gene CCL2 and polycystic ovary syndrome.